A central theme of those processes will be the use of flexible, automated, and closed process
technologies such as GE's
cell -
expansion systems and Xcellerex bioreactors to produce new
technologies that can manage data collection and management, quality control and analysis, raw materials, and cost reduction.
It might be possible in the near future to use one of the new forms of genetic
technology to tackle the clonal
expansions of specific mutations, provided there are only a few of them and they are present in large numbers of
cells.